144 related articles for article (PubMed ID: 7622828)
21. Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.
Agid O; Foussias G; Remington G
Expert Opin Pharmacother; 2010 Oct; 11(14):2301-17. PubMed ID: 20586707
[TBL] [Abstract][Full Text] [Related]
22. [Detection of early warning signs in schizophrenic patients. Possible applications in prevention of recurrence].
Wiedemann G; Hahlweg K; Hank G; Feinstein E; Müller U; Dose M
Nervenarzt; 1994 Jul; 65(7):438-43. PubMed ID: 7800087
[TBL] [Abstract][Full Text] [Related]
23. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment.
Viguera AC; Baldessarini RJ; Hegarty JD; van Kammen DP; Tohen M
Arch Gen Psychiatry; 1997 Jan; 54(1):49-55. PubMed ID: 9006400
[TBL] [Abstract][Full Text] [Related]
24. Maintenance medication for schizophrenia: strategies for dose reduction.
Schooler NR
Schizophr Bull; 1991; 17(2):311-24. PubMed ID: 1679254
[TBL] [Abstract][Full Text] [Related]
25. Prevention and management of tardive dyskinesia.
Jeste DV; Wyatt RJ
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
[TBL] [Abstract][Full Text] [Related]
26. Prediction of outcome in first-episode schizophrenia.
Lieberman JA
J Clin Psychiatry; 1993 Mar; 54 Suppl():13-7. PubMed ID: 8097192
[TBL] [Abstract][Full Text] [Related]
27. A randomised controlled trial of prophylactic neuroleptic treatment.
Crow TJ; MacMillan JF; Johnson AL; Johnstone EC
Br J Psychiatry; 1986 Feb; 148():120-7. PubMed ID: 2870753
[TBL] [Abstract][Full Text] [Related]
28. Prevention of relapse in chronic schizophrenic patients.
Hogarty GE
J Clin Psychiatry; 1993 Mar; 54 Suppl():18-23. PubMed ID: 8097193
[TBL] [Abstract][Full Text] [Related]
29. TAILOR - tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial.
Stürup AE; Jensen HD; Dolmer S; Birk M; Albert N; Nielsen M; Hjorthøj C; Eplov L; Ebdrup BH; Mors O; Nordentoft M
Trials; 2017 Sep; 18(1):445. PubMed ID: 28962668
[TBL] [Abstract][Full Text] [Related]
30. Early, targeted pharmacotherapeutic intervention in schizophrenia.
Carpenter W
J Clin Psychiatry; 1986 May; 47 Suppl():23-9. PubMed ID: 2871012
[TBL] [Abstract][Full Text] [Related]
31. Maintenance therapy of persons with schizophrenia.
Carpenter WT
J Clin Psychiatry; 1996; 57 Suppl 9():10-8. PubMed ID: 8823345
[TBL] [Abstract][Full Text] [Related]
32. Risks of intermittent antipsychotic treatment in schizophrenia.
Suzuki T; Nomura K; Watanabe K
J Clin Psychiatry; 2011 Jan; 72(1):114; author reply 114-5. PubMed ID: 21272519
[No Abstract] [Full Text] [Related]
33. Considering neuroleptic maintenance and taper on a continuum. Need for individual rather than dogmatic approach.
Jeste DV; Gilbert PL; McAdams LA; Harris MJ
Arch Gen Psychiatry; 1995 Mar; 52(3):209-12. PubMed ID: 7872848
[No Abstract] [Full Text] [Related]
34. Review of antipsychotic medication administration: a proposal of intermittent dosing.
Boshes RA; Manschreck TC
Schizophr Bull; 2002; 28(2):203-22. PubMed ID: 12693428
[TBL] [Abstract][Full Text] [Related]
35. Prodromal states in schizophrenia.
Gaebel W; Jänner M; Frommann N; Pietzcker A; Köpcke W; Linden M; Müller P; Müller-Spahn F; Tegeler J
Compr Psychiatry; 2000; 41(2 Suppl 1):76-85. PubMed ID: 10746908
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
[TBL] [Abstract][Full Text] [Related]
37. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems.
Mukundan A; Faulkner G; Cohn T; Remington G
Cochrane Database Syst Rev; 2010 Dec; (12):CD006629. PubMed ID: 21154372
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological prevention of relapse.
Lader M
Kaohsiung J Med Sci; 1998 Jul; 14(7):448-57. PubMed ID: 9739577
[TBL] [Abstract][Full Text] [Related]
39. Neuroleptic plasma levels and tardive dyskinesia: a possible link?
Nasrallah HA
Schizophr Bull; 1980; 6(1):4-7. PubMed ID: 6102792
[TBL] [Abstract][Full Text] [Related]
40. [Discontinuation of neuroleptics in chronic schizophrenics. I. Summary of the literature].
Woggon B
Int Pharmacopsychiatry; 1979; 14(1):34-56. PubMed ID: 39040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
